Merck & Co., Inc. (NYSE: MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection ...

This degree of success can become a double-edged sword, though. While the drug has thrived since its first approval back in ...

With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.

Kennedy’s advisers scrap hepatitis B vaccine guidance for most children in major policy shift – Nation and World News | West Hawaii Today ...

The cash-and-stock deal would give the world’s largest paid streaming service expansive power over theater owners and ...

If you own or are considering buying pharma laggards Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and Merck (NYSE: ...

The deal to acquire the Hollywood behemoth’s television and film studios as well as HBO Max will bulk up the world’s biggest ...

A group of vaccine advisers today scrapped a long-standing recommendation that all U.S. children receive the hepatitis B shot at birth, a major policy win for health secretary Robert F. Kennedy Jr ...

Dec 5 (Reuters) - Vaccine makers expressed concern on Friday's decision by a U.S. advisory panel to scrap its long-standing ...

Finally, Merck is an excellent dividend stock. It offers a juicy forward yield of 3.2% and has increased its payouts by 93.8% ...

An influential panel of US vaccine advisers voted to revoke a longstanding recommendation that all babies receive hepatitis B shots within 24 hours of birth.